Fig. 2
Vital signs and bispectral index during the entire procedure. Evaluation of the levels of (A) bispectral index, (B) SBP, (C) DBP, (D) HR and (E) SpO2 before induction (T1), after induction (T2), after laryngeal mask airway insertion (T3), 5 min after the beginning of surgery (T4), 10 min after the beginning of surgery (T5), 10 min before stopping the study drug (T6), 5 min before stopping the study drug (T7), immediately after stopping the study drug (T8), 10 min after stopping the study drug (T9), 15 min after stopping the study drug (T10), after laryngeal mask airway extraction (T11) and before leaving the operating room (T12). Data are shown as mean ± SE or median. SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; SpO2, blood oxygen saturation; RT, remimazolam tosilate; LoC, loss of consciousness. *P < 0.05, **P < 0.01, ***P < 0.001, RT + flumazenil versus propofol group; #P < 0.05, ##P < 0.01, ###P < 0.001, RT versus propofol group